Showing results (201-210 of 1,343) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|December 14, 2011
A pharmacogenetic study of ADRB2 polymorphisms and indacaterol response in COPD patientsR Yelensky, Y Li, S Lewitzky, et al.
The Pharmacogenomics Journal|December 14, 2011
DNA-damage response gene polymorphisms and therapeutic outcomes in ovarian cancerE Caiola, L Porcu, R Fruscio, et al.
The Pharmacogenomics Journal|December 14, 2011
Pharmacogenetic predictors for EGFR-inhibitor-associated skin toxicityS Parmar, C Schumann, S Rüdiger, et al.
The Pharmacogenomics Journal|January 18, 2012
Novel mRNA isoforms and mutations of uridine monophosphate synthetase and 5-fluorouracil resistance in colorectal cancerM Griffith, J C Mwenifumbo, P Y Cheung, et al.
The Pharmacogenomics Journal|January 18, 2012
Pharmacogenetic investigation of response to duloxetine treatment in generalized anxiety disorderR H Perlis, B Fijal, S Dharia, et al.
The Pharmacogenomics Journal|February 8, 2012
Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor geneN I Chowdhury, A K Tiwari, R P Souza, et al.
The Pharmacogenomics Journal|February 8, 2012
Beyond single-marker analyses: mining whole genome scans for insights into treatment responses in severe sepsisM Man, S L Close, A D Shaw, et al.
The Pharmacogenomics Journal|July 13, 2011
Genetic clustering of European cancer patients indicates that opioid-mediated pain relief is independent of ancestryA Galvan, T Fladvad, F Skorpen, et al.
The Pharmacogenomics Journal|June 1, 2011
Cytidine deaminase single-nucleotide polymorphism is predictive of toxicity from gemcitabine in patients with pancreatic cancer: RTOG 9704J J Farrell, K Bae, J Wong, et al.
The Pharmacogenomics Journal|June 1, 2011
An update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with drug pharmacokineticsS J Wolf, M Bachtiar, J Wang, et al.
Pageof 135